Designer Benzodiazepines

Date and Time: September 26, 2023

Length: 15 minutes

Synthetic Cannabinoids

Date and Time: August 29, 2023

Length: 15 minutes

Xylazine: A New Deadly Threat to Public Health

Date and Time: August 16, 2023

Length: 40 minutes

Polysubstance Use: Fentanyl and Stimulants

Date and Time: July 25, 2023

Length: 15 minutes

Spotlight on Potential Interactions Involving Behavioral Health & Substance Use Disorder Medications

Date and Time: June 27, 2023

Length: 15 minutes

Managing Neonatal Abstinence Syndrome: Screening and Medication Monitoring

Date and Time: May, 25, 2023

Length: 15 minutes

Novel Psychoactive Substances: Newly Identified Threats Detected in the Second Half of 2022

Date and Time: March 28, 2023

Length: 25 minutes

Impacts of Bariatric Surgery

Date and Time: February 23, 2023

Length: 25 minutes

Novel Psychoactive Substances: What is Xylazine?

Date and Time: January 24, 2023

Length: 15 minutes

Behavioral Health: Why Monitor Patients for Medication Adherence

Date and Time: August 31, 2022

Length: 15 minutes

Novel Psychoactive Substances: What is Xylazine?

Date and Time: January 24,2023

Length: 15 minutes

InterACT Rx: A Look at Clinical Utility Through a Discussion of Interactions Found Webinar

Date and Time: June 24, 2022

Length: 15 minutes

BioDetect Identifying Non-Urine Substances (May22)

Date and Time: May 24, 2022

Length: 15 minutes

Unpredictability of Counterfeit Drugs

Date and Time: January 20, 2022

Length: 22 minutes

Novel Psychoactive Testing in Oral Fluid Webinar

Date and Time: December 16, 2021

Length: 21 minutes

Opioid Drug Interactions: Ongoing Awareness Amidst the COVID-19 Pandemic and Opioid Epidemic

Date and Time: October 28, 2021

Length: 13 minutes

Medication Monitoring Program Essentials Webinar (2021)

Date and Time: November 18, 2021

Length: 13 minutes

Staying Safe: The Importance of Medication Monitoring as the Pandemic Continues

Date and Time: September 23, 2021

Length: 11 minutes

Cases of Unusual Buprenorphine Concentrations in Urine Drug Tests: What Does This Mean and Clinical Implications?

Date and Time: August 31, 2021

Length: 15 minutes

Toolkit for Buprenorphine Practices

Date and Time: July 29, 2021

Length: 30 minutes

A Solution for Detecting DDIs: A Severely Underrecognized Problem That Can Be Effectively Addressed

Date and Time: December 9, 2021

Length: 21 minutes

Finding Fentanyl

Date and Time: June 24, 2021

Length: 15 minutes

NPS Focus: "Nitazene" Synthetic Opioids

Date and Time: July 22, 2021

Length: 15 minutes

Interpretation of Buprenorphine Results: Considerations for Dosage Form and Specimen Type

Date and Time: May 20, 2021

Length: 15 minutes

Trends in Novel Psychoactive Substances

Date and Time: April 29, 2021

Length: 30 minutes

NPS Focus: Designer Benzodiazepines

Date and Time: March 25, 2021

Length: 15 minutes

Expansion of Urine Behavioral Health Drug Testing, AcuRiseID™

Date and Time: Feb 25, 2021

Length: 11 minutes

Increase in Drug Overdoses Due to Synthetic Opioids During the COVID-19 Pandemic

Date and Time: January 28, 2021

Length: 14 minutes

What Did My Patient Actually Take? An Overview of Dextromethorphan/Levorphanol Results

Date and Time: December 17, 2020

Length: 12 minutes

COVID-19 and Its Impact on Persons with Mental Illness and Substance Use

Date and Time: October 29, 2020

Length: 15 minutes

Drug-Drug Interactions (DDI) amidst the Pandemic and Opportunities for Objective DDI Monitoring via Oral Fluid Testing

Date and Time: December 3, 2020

Length: 16 minutes

Emerging Data on Novel Psychoactive Substances and Clinical Effects

Date and Time: September 23, 2020

Length: 15 minutes

Novel Psychoactive Substance Testing

Date and Time: September 13, 2020

Length: 37 minutes

Designer Opioids and Benzodiazepines

Date and Time: August 27, 2020

Length: 19 minutes

Synthetic Cannabinoids and Synthetic Stimulants

Date and Time: July 23, 2020

Length: 9 minutes

Expansion of Oral Fluid Testing of Behavioral Health Drugs

Date and Time: June 23, 2020

Length: 13 minutes

Review of New InterAct Rx Analyte Positivity

Date and Time: May 28, 2020

Length: 9 minutes

An Overview of Oral Fluid Testing

Date and Time: May 13, 2020

Length: 13 minutes

Downstream effects of COVID-19 on your patients

Date and Time: April 21, 2020

Length: 30 minutes

Kratom: New Year, New Insights

Date and Time: February 4, 2020

Length: 10 minutes

Introduction to PGx for Pain Management

Date and Time: March 26, 2020

Length: 15 minutes

What Did My Patient Actually Take? A Review of Opioid Results Interpretation

Date and Time: November 21, 2019

Length: 12 minutes

What Did My Patient Actually Take? An Overview of Benzodiazepine Results

Date and Time: December 17, 2019

Length: 12 minutes

What Did My Patient Actually Take? Unexpected Causes of Cocaine Results

Date and Time: August 29, 2019

Length: 15 minutes

What Did My Patient Actually Take? An Overview of Methamphetamine Results

Date and Time: July 17, 2019

Length: 13 minutes

What Did My Patient Actually Take? An Overview of Amphetamine Results

Date and Time: June 27, 2019

Length: 13 minutes

What Did My Patient Actually Take? An Overview of Marijuana Results

Date and Time: October 24, 2019

Length: 8 minutes

Enhanced DDI Identification and Patient Care with InterACT Rx

Date and Time: March 15, 2019

Length: 27 minutes

Medication Monitoring Program Essentials

Date and Time: February 26th, 2019

Length: 31 minutes